Loading…
Brittany Wilkinson Mitochondrial Disease Research and Treatment Enhancement Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 4,048 other S bills in the 111th — cohort avg 29d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2010 · fourth_quarter · Budget/Appropriations
Promote awareness and federal funding for mitochondrial disease research, including through FY11 Labor, HHS & Education Appropriations Act (Title II - National Institutes of Health), and authorization bill (H.R. 3502); S.2858.
Client expense: Not reported · Firm income: $20,000
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Health Issues
Promote awareness and federal funding for mitochondrial disease research, including through FY11 Labor, HHS & Education Appropriations Act (Title II - National Institutes of Health), and authorization bill (H.R. 3502; S.2858).
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Budget/Appropriations
Promote awareness and federal funding for mitochondrial disease research, including through FY11 Labor, HHS & Education Appropriations Act (Title II - National Institutes of Health), and authorization bill (H.R. 3502); S.2858.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Health Issues
Promote awareness and federal funding for mitochondrial disease research, including through FY11 Labor, HHS & Education Appropriations Act (Title II - National Institutes of Health), and authorization bill (H.R. 3502; S.2858).
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Health Issues
Promote awareness and federal funding for mitochondrial disease research, including through FY11 Labor, HHS & Education Appropriations Act (Title II - National Institutes of Health), and authorization bill (H.R. 3502; S.2858).
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Budget/Appropriations
Promote awareness and federal funding for mitochondrial disease research, including through FY11 Labor, HHS & Education Appropriations Act (Title II - National Institutes of Health), and authorization bill (H.R. 3502); S.2858.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Budget/Appropriations
Promote awareness and federal funding for mitochondrial disease research, including through FY11 Labor, HHS & Education Appropriations Act (Title II - National Institutes of Health), and authorization bill (H.R. 3502); S.2858.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Health Issues
Promote awareness and federal funding for mitochondrial disease research, including through FY11 Labor, HHS & Education Appropriations Act (Title II - National Institutes of Health), and authorization bill (H.R. 3502; S.2858).
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Democratic |
| MA |
| Maria Cantwell | Democratic | WA |
| Richard J. Durbin | Democratic | IL |
| Robert P. Casey, Jr. | Democratic | PA |